Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-25-074641
Filing Date
2025-04-07
Accepted
2025-04-07 16:06:09
Documents
18
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d898463d10ka.htm   iXBRL 10-K/A 121456
2 EX-19.1 d898463dex191.htm EX-19.1 55493
3 EX-31.3 d898463dex313.htm EX-31.3 4188
4 EX-31.4 d898463dex314.htm EX-31.4 4156
  Complete submission text file 0001193125-25-074641.txt   421941

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mrus-20241231.xsd EX-101.SCH 4562
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mrus-20241231_cal.xml EX-101.CAL 645
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrus-20241231_def.xml EX-101.DEF 18185
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrus-20241231_lab.xml EX-101.LAB 24167
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrus-20241231_pre.xml EX-101.PRE 19465
21 EXTRACTED XBRL INSTANCE DOCUMENT d898463d10ka_htm.xml XML 8259
Mailing Address YALELAAN 62 3584 CM UTRECHT DE
Business Address YALELAAN 62 3584 CM UTRECHT DE 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37773 | Film No.: 25818165
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)